Download Free Sample Report

Implantable Drug-Eluting Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Implantable Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type

• Implantable Drug Infusion Pumps
• Intraocular Drug-Eluting Devices
• Contraceptive Drug-Eluting Devices
• Drug-Eluting Stents
• Others

Segment by Application

• Diabetes
• Contraception
• HIV/AIDS Prevention
• Chronic Pain Management
• Cardiovascular
• Ophthalmology
• Oncology
• Others

By Company

• Pfizer
• Medtronic
• Merck
• Bayer AG
• Johnson & Johnson
• Abbott
• Surmodics
• Boston Scientific Corporation
• Titan Pharmaceuticals, Inc.
• BIOTRONIK
• Allergan
• Bausch & Lomb
• REVA Medical
• MicroPort Medical

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E